Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.950
-0.020 (-0.67%)
At close: Jun 2, 2026, 4:00 PM EDT
3.000
+0.050 (1.69%)
After-hours: Jun 2, 2026, 6:33 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $131.01 million as of June 2, 2026. Its market cap has increased by 41.62% in one year.
Market Cap
131.01M
Enterprise Value
107.29M
1-Year Change
41.62%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $131.01M, a decrease of -7.54%. That is a compound annual growth rate of -2.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 131.01M | -20.13% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 140.40M |
| Corbus Pharmaceuticals Holdings | 139.70M |
| TuHURA Biosciences | 138.83M |
| Connect Biopharma Holdings | 135.37M |
| Kazia Therapeutics | 134.72M |
| Alpha Cognition | 134.56M |
| Canton Strategic Holdings | 134.28M |
| Spruce Biosciences | 133.22M |